{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:19:06Z","timestamp":1767626346296},"reference-count":61,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"VECTORIE","award":["261466"],"award-info":[{"award-number":["261466"]}]},{"name":"FLUNIVAC","award":["602604"],"award-info":[{"award-number":["602604"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.02.042","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:56:08Z","timestamp":1456966568000},"page":"1915-1926","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens"],"prefix":"10.1016","volume":"34","author":[{"given":"Asisa","family":"Volz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Kaserer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"L\u00fclf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Marr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Jany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia A.","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorben P.","family":"Pijlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Koraka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron E.","family":"Martina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Jan","key":"10.1016\/j.vaccine.2016.02.042_bib0310","first-page":"89","article-title":"West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases","volume":"59","author":"Goldblum","year":"1954","journal-title":"Am J Hyg"},{"issue":"Mar","key":"10.1016\/j.vaccine.2016.02.042_bib0315","first-page":"19508","article-title":"West Nile virus in Europe: understanding the present to gauge the future","volume":"11","author":"Reiter","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10096-003-1085-1","article-title":"West Nile virus: an overview of its spread in Europe and the Mediterranean Basin in contrast to its spread in the Americas","volume":"23","author":"Zeller","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0325","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the Northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1051\/vetres\/2010039","article-title":"West Nile virus and its emergence in the United States of America","volume":"41","author":"Murray","year":"2010","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0335","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","article-title":"The Outbreak of West Nile virus infection in the New York City area in 1999","volume":"344","author":"Nash","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcv.2012.08.024","article-title":"Flaviviruses and their antigenic structure","volume":"55","author":"Heinz","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0345","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1128\/JVI.75.22.10787-10799.2001","article-title":"Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively","volume":"75","author":"Mackenzie","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0350","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1863-2378.2008.01208.x","article-title":"The zoonotic flaviviruses of southern, South-Eastern and Eastern Asia, and Australasia: the potential for emergent viruses","volume":"56","author":"Mackenzie","year":"2009","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0355","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3201\/eid2012.140921","article-title":"Putative new West Nile virus lineage in Uranotaenia unguiculata Mosquitoes, Austria, 2013","volume":"20","author":"Karin","year":"2014","journal-title":"Emerg Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0360","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.20.21135","article-title":"The challenge of West Nile virus in Europe: knowledge gaps and research priorities","volume":"20","author":"Rizzoli","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0365","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3201\/eid1204.051379","article-title":"Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe","volume":"12","author":"Bakonyi","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0370","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid1705.101759","article-title":"Genetic characterization of West Nile virus lineage 2, Greece, 2010","volume":"17","author":"Papa","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0375","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1016\/j.vaccine.2005.02.020","article-title":"Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge","volume":"23","author":"Karaca","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0380","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1016\/j.vaccine.2011.04.058","article-title":"Protection provided by a recombinant ALVAC\u00ae-WNV vaccine expressing the prM\/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain","volume":"29","author":"Minke","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0385","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/v5102384","article-title":"Vaccines in development against West Nile virus","volume":"5","author":"Brandler","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0390","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/infdis\/jir054","article-title":"A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial","volume":"203","author":"Ledgerwood","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0395","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0400","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0405","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1074\/jbc.M506614200","article-title":"Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor \u03b1V\u03b23 integrin","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0410","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1128\/JVI.79.13.8339-8347.2005","article-title":"Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains","volume":"79","author":"Beasley","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0415","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0420","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0425","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-61779-876-4_4","article-title":"Easy and efficient protocols for working with recombinant vaccinia virus MVA","volume":"2","author":"Kremer","year":"2012","journal-title":"Vaccinia Virus Poxvirol Methods Protoc"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0430","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model","volume":"14","author":"Wyatt","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0435","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0440","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0445","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/eji.200425463","article-title":"A mouse model of human adaptive immune functions: HLA-A2.1-\/HLA-DR1-transgenic H-2 class I-\/class II-knockout mice","volume":"34","author":"Pajot","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-8-353","article-title":"Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells","volume":"8","author":"Metz","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0455","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1073\/pnas.0711874105","article-title":"Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes","volume":"105","author":"McMurtrey","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0460","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jviromet.2013.07.050","article-title":"Development of a strand-specific real-time qRT-PCR for the accurate detection and quantitation of West Nile virus RNA","volume":"194","author":"Lim","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0465","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2217\/fmb.14.67","article-title":"Technologies for the development of West Nile virus vaccines","volume":"9","author":"Ulbert","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0470","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/JVI.02329-09","article-title":"Preclinical studies of a Modified Vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect","volume":"84","author":"Brandler","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0475","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S1473-3099(14)70963-6","article-title":"Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1\/2a clinical trial","volume":"14","author":"Kreijtz","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0480","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.vaccine.2009.03.020","article-title":"Preclinical evaluation of a Modified Vaccinia virus Ankara (MVA)-based vaccine against influenza A\/H5N1 viruses","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0485","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/595984","article-title":"Recombinant Modified Vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques","volume":"199","author":"Kreijtz","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0490","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/517614","article-title":"Recombinant Modified Vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1","volume":"195","author":"Kreijtz","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0495","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3201\/eid2106.150021","article-title":"Induction of influenza (H5N8) antibodies by Modified Vaccinia virus Ankara H5N1 vaccine","volume":"21","author":"Rory","year":"2015","journal-title":"Emerg Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0500","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3201\/eid2106.150021","article-title":"Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine","volume":"21","author":"de Vries","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0505","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s007050050646","article-title":"Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins","volume":"144","author":"Falconar","year":"1999","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0510","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The structural immunology of antibody protection against West Nile virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0515","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jviromet.2015.01.004","article-title":"Monoclonal antibody against Saint Louis encephalitis prM viral protein","volume":"218","author":"Pupo-Ant\u00fanez","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0520","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","article-title":"Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form","volume":"69","author":"Allison","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0525","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01309465","article-title":"Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells","volume":"139","author":"Delenda","year":"1994","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0530","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0034-5288(94)90056-6","article-title":"Recombinant vaccinia virus expressing PrM and E Glycoproteins of louping ill virus: induction of partial homologous and heterologous protection in mice","volume":"57","author":"Venugopal","year":"1994","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0535","doi-asserted-by":"crossref","first-page":"e91766","DOI":"10.1371\/journal.pone.0091766","article-title":"A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB\/c mice","volume":"9","author":"Nzonza","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0540","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0545","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0550","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis","volume":"191","author":"Despr\u00e8s","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0555","doi-asserted-by":"crossref","first-page":"13262","DOI":"10.1128\/JVI.79.21.13262-13274.2005","article-title":"N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity","volume":"79","author":"Hanna","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0560","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.micinf.2009.07.009","article-title":"Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM\/M-E virus-like particles of West Nile virus","volume":"11","author":"Takahashi","year":"2009","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0565","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1128\/JVI.00037-07","article-title":"Structure of immature West Nile virus","volume":"81","author":"Zhang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0570","series-title":"Advances in virus research","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","author":"Lindenbach","year":"2003"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0575","doi-asserted-by":"crossref","first-page":"e8325","DOI":"10.1371\/journal.pone.0008325","article-title":"Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins","volume":"4","author":"Wang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0580","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4049\/jimmunol.181.2.1563","article-title":"The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes","volume":"181","author":"Parsons","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent progress in West Nile virus diagnosis and vaccination","volume":"43","author":"De Filette","year":"2012","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0590","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.4049\/jimmunol.181.12.8568","article-title":"West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection","volume":"181","author":"Brien","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0595","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3390\/v5102573","article-title":"CD8 and CD4 T cells in West Nile virus immunity and pathogenesis","volume":"5","author":"Netland","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0600","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection","volume":"37","author":"Brien","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0605","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.042_bib0610","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1084\/jem.20090222","article-title":"Key role of T cell defects in age-related vulnerability to West Nile virus","volume":"206","author":"Brien","year":"2009","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T08:50:13Z","timestamp":1654505413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":61,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16002139"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}